← Open Payments lookup

IMRAN IQBAL: Open Payments

NPI 1306070040 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,884 in 179 payments from 16 companies in 2025. Trend: 2023 $1,503 · 2024 $1,793 · 2025 $2,884

Food & beverage: $2,884
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$392
Neurocrine BioSciences, Inc.26$376
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$274
Vanda Pharmaceuticals Inc.10$271
Alkermes, Inc.12$239
ABBVIE INC.23$229
E.R. Squibb & Sons, L.L.C.14$191
Corium, LLC10$144
Axsome Therapeutics, Inc.12$136
Noven Therapeutics, LLC7$134

Products named: INGREZZA, CAPLYTA, FANAPT, ABILIFY MAINTENA, REXULTI, LYBALVI, VRAYLAR, COBENFY.

Industry payments across KY — which companies pay providers there.